The Biomarkers for the Diagnosis, Prognosis and Treatments Response in Digestive Disorders

Dear Colleagues,

The management of cancer involves the use of biomarkers from diagnosis to follow up, exceeding the effectiveness of therapeutic radio-chemotherapy or surgical treatments. In addition, in patients with digestive disorders, biomarkers have a crucial role in the fight against this deathful disease.

The role of this Special Issue is to report the most recent knowledge regarding the relationship between biomarkers and digestive disorders. Furthermore, much attention will be paid to the contributions that highlight the potential role that markers may play in guiding therapeutic decisions (e.g., to start neoadjuvant treatments or not) in the treatment of digestive disorders.

Another interesting aspect is the role of markers in precancerous diseases and in aiding the early diagnosis of digestive disorders, as they appear to improve survival in these cases.

Finally, the use of markers as a tool for evaluating the effect of neoadjuvant, surgical and adjuvant treatments on the response to therapy, as well as their role in the follow up, will be discussed.

You are kindly invited to share your knowledge, purposes, and recent advances in digestive disorders, focused on biomarkers, in this Special Issue of Biomedicines.

Dr. Alessandro Coppola
Dr. Michele Fiore
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomedicines is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.